Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricONCBeOne Medicines AGBIIBBiogenMRNAModerna
Snapshot
Price$372.18$217.39$140.48
Market cap$33.43B$31.91B$31.65B
Valuation
P/E71.9x23.6x—
Forward P/E—25.6x—
Growth
Revenue growth36.2%1.2%-30.0%
EPS growth—-8.1%—
Profitability
Net margin7.8%13.8%-143.6%
ROE5.2%7.5%-36.7%
Balance sheet & cash
Debt / equity0.25x0.34x0.07x
Free cash flow yield—6.8%-13.6%
Dividend yield———
Verdict
Investment ratingNeutral· 48Neutral· 49Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearONCtoday $372BIIBtoday $217MRNAtoday $140
2027$380.13 – $557.52+50% CAGR$166.30 – $243.91+12% CAGR$107.47 – $157.62+12% CAGR
2028$517.66 – $759.23+43% CAGR$169.63 – $248.79+7% CAGR$109.62 – $160.77+7% CAGR
2029$704.94 – $1,033.92+41% CAGR$173.02 – $253.77+5% CAGR$111.81 – $163.99+5% CAGR
2030$959.99 – $1,407.99+39% CAGR$176.48 – $258.84+4% CAGR$114.05 – $167.27+4% CAGR
2031$1,307.32 – $1,917.40+39% CAGR$180.01 – $264.02+4% CAGR$116.33 – $170.61+4% CAGR
5-yr CAGR28.6% – 38.8%-3.7% – 4.0%-3.7% – 4.0%